172 related articles for article (PubMed ID: 14603040)
1. Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.
Shibuya TY; Kim S; Nguyen K; Parikh P; Wadhwa A; Brockardt C; Do J
Laryngoscope; 2003 Nov; 113(11):1870-84. PubMed ID: 14603040
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
[TBL] [Abstract][Full Text] [Related]
3. Bioactive suture: a novel immunotherapy for head and neck cancer.
Shibuya TY; Kim S; Nguyen K; Do J; McLaren CE; Li KT; Chen WP; Parikh P; Wadhwa A; Zi X; Chen VY; Wong HS; Armstrong WB; Yoo GH
Clin Cancer Res; 2004 Oct; 10(20):7088-99. PubMed ID: 15501989
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
[TBL] [Abstract][Full Text] [Related]
5. Linking of bone morphogenetic protein-2 to resorbable fracture plates for enhancing bone healing.
Shibuya TY; Wadhwa A; Nguyen KH; Panossian AM; Kim S; Wong H; Feinberg S; Damisah EC; Camilon PR; Bang H
Laryngoscope; 2005 Dec; 115(12):2232-7. PubMed ID: 16369172
[TBL] [Abstract][Full Text] [Related]
6. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
7. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
8. Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck.
Dadian G; Riches PG; Henderson DC; MacLennan K; Lorentzos A; Moore J; Hobbs JR; Gore ME
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):29-34. PubMed ID: 8180573
[TBL] [Abstract][Full Text] [Related]
9. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
10. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral administration of recombinant human interleukin 12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodes.
van Herpen CM; Looman M; Zonneveld M; Scharenborg N; de Wilde PC; van de Locht L; Merkx MA; Adema GJ; de Mulder PH
Clin Cancer Res; 2004 Apr; 10(8):2626-35. PubMed ID: 15102664
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
14. Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.
Wolf GT; Fee WE; Dolan RW; Moyer JS; Kaplan MJ; Spring PM; Suen J; Kenady DE; Newman JG; Carroll WR; Gillespie MB; Freeman SM; Baltzer L; Kirkley TD; Brandwein HJ; Hadden JW
Head Neck; 2011 Dec; 33(12):1666-74. PubMed ID: 21284052
[TBL] [Abstract][Full Text] [Related]
15. The immunopharmacology of head and neck cancer: an update.
Hadden JW
Int J Immunopharmacol; 1997; 19(11-12):629-44. PubMed ID: 9669203
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
17. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
18. Immunologic effector cells in head and neck cancer.
Vitolo D; Letessier EM; Johnson JT; Whiteside TL
J Natl Cancer Inst Monogr; 1992; (13):203-8. PubMed ID: 1356393
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Schoppy DW; Sunwoo JB
Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
